Fujifilm Expands Fill Finish Services

Fujifilm Diosynth Biotechnologies extended its gene therapy and viral vaccine fill/finish capabilities to provide services in support of late-phase candidates and commercial supply. Fujifilm has invested in Vanrx Pharmasystems’ SA25 Aseptic Filling Workcell gloveless isolator technology with automated environmental monitoring and no glass-to-glass contact.  Fujifilm’s fill/finish services offer rapid changeover between drug products and containers, production